F-FDG PET achieved an AUC of 0.92 for identifying malignant cardiac masses, and its addition after CMR or CCT improved diagnostic classification.
Observational
Does F-FDG PET accurately identify malignant cardiac masses compared to histology?
F-FDG PET demonstrates high diagnostic accuracy (AUC 0.92) for identifying malignant cardiac masses and provides incremental value when added to CMR or CCT.
Effect estimate: AUC 0.92
BACKGROUND: F-FDG) positron emission tomography (PET) remains incompletely defined. OBJECTIVES: F-FDG PET, individually and in combination, for identifying malignant CMs using histology as the reference standard. METHODS: F-FDG PET within 2 months of first medical contact. Final diagnosis was established by histology or radiological resolution after anticoagulation therapy for thrombi. Diagnostic performance was assessed using receiver-operating characteristic curves, and the areas under the curve (AUCs) were compared with the DeLong test, applying Bonferroni correction for multiple comparisons. CART (Classification And Regression Tree) analysis assessed the incremental value of PET following CMR or CCT. RESULTS: F-FDG PET achieved an AUC of 0.92. The addition of PET after CMR or CCT was associated with improved diagnostic classification in selected cases, as supported by CART analysis. CONCLUSIONS: F-FDG PET represents a reliable alternative.
Angeli et al. (Fri,) conducted a observational in Cardiac Masses. F-FDG PET vs. Histology or radiological resolution was evaluated on Identifying malignant cardiac masses (AUC 0.92). F-FDG PET achieved an AUC of 0.92 for identifying malignant cardiac masses, and its addition after CMR or CCT improved diagnostic classification.